2026 NPPES data Neurology Physician NPI 1205009115 M.D.
Verify on CMS →

Jeffrey Gelfand, M.D.

Neurology Physician in San Francisco, California.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 20,467 in Neurology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
631
Medicare Part D claims · 81 beneficiaries · Neurology Physician avg: 1K
Generic prescribing
88%
generic claims · 12% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
91.9/100
▲ 8 pts above national avg 83.5 · Exceptional

What the federal data shows

Jeffrey Gelfand, M.D. reported a CMS MIPS final score of 91.9/100 - above the 83.5 national average - and filed 631 Medicare Part D claims in 2024.

91.9/100
MIPS score · +8 vs avg
631
Part D claims, 2024
88%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Federal trust snapshot

What official records show about Jeffrey Gelfand, M.D.

Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.

  • Verified

    NPI registry status

    Active listing in the CMS National Provider Identifier Registry (NPI 1205009115), first enumerated 04/11/2008.

    Source: CMS NPPES

  • Reported

    Medicare Part D participation

    Filed 631 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.

    Source: CMS Part D Prescriber PUF

  • Reported

    CMS quality reporting (MIPS)

    Reported a CMS MIPS final score of 91.9/100 in the Quality Payment Program — a federal quality measure, not a patient review.

    Source: CMS Quality Payment Program

  • Reported

    Board certification signal

    Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.

    Source: NUCC taxonomy + CMS participation heuristic

  • Reported

    Hospital affiliations

    2 CMS Care Compare hospital affiliations on record — practice footprint from the Doctors and Clinicians file.

    Source: CMS Care Compare

  • State context

    State board disciplinary context

    California statewide board action statistics are published annually — these figures describe aggregate state activity, not Jeffrey Gelfand, M.D.'s individual license status. Verify directly with the state medical board.

    Source: MBC annual report 2023

  • Not in federal data

    Individual sanction lookup

    PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.

    Source: State medical board / FSMB

This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.

CMS NPPES provider registry desk

NPI 1205009115 · Neurology Physician

NPI-10 · ENUM-MID · TAX-MID · MIPS-ABOVE · RX-LIGHT · BOOK-LIGHT · PHOTO-FINISH

  • NPI-10 1205009115
  • ENUM-MID 2008
  • TAX-MID 20K Neurology Physician
  • MIPS-ABOVE 91.9/100
  • RX-LIGHT 631
  • BOOK-LIGHT 2,160 in California
  • PHOTO-FINISH Christopher Green, M… · ±0.0

MIPS final-score neighbourhood

Same-specialty nationwide peers by CMS final score, not geographic proximity

MIPS pts

What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).

Source CMS Quality Payment Program (MIPS) As of 2023

Jeffrey Gelfand, M.D.'s MIPS score vs every measured U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.

92 ≥ 61st percentile 61% of 454,083 measured providers are in lower value bands

0–10: 8,684 measured providers (2%). Below this entry. 10–20: 3,008 measured providers (1%). Below this entry. 20–30: 3,069 measured providers (1%). Below this entry. 30–40: 2,746 measured providers (1%). Below this entry. 40–50: 2,928 measured providers (1%). Below this entry. 50–60: 5,882 measured providers (1%). Below this entry. 60–70: 13,906 measured providers (3%). Below this entry. 70–80: 94,570 measured providers (21%). Below this entry. 80–90: 129,887 measured providers (29%). Below this entry. 90+: 189,403 measured providers (42%). This entry sits in this band. This provider 0 100 every measured MIPS clinician, bucketed by value

Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Where Jeffrey Gelfand, M.D. sits

This provider among neurology physician peers

Across the 5,099 neurology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Jeffrey Gelfand, M.D. writes more Part D claims than 40% of them and scores higher on MIPS quality than 65% - placing this provider in the lower-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.

Lower volume · High qualityHigh volume · High qualityLower volume · Lower qualityHigh volume · Lower quality0255075100024.148.372.496.6Part D claim volume, percentile in specialtyMIPS quality, percentilePoint, Part D claim volume, percentile in specialty: 45 · MIPS quality, percentile: 35Point, Part D claim volume, percentile in specialty: 87 · MIPS quality, percentile: 28Point, Part D claim volume, percentile in specialty: 40 · MIPS quality, percentile: 83Point, Part D claim volume, percentile in specialty: 78 · MIPS quality, percentile: 70Point, Part D claim volume, percentile in specialty: 88 · MIPS quality, percentile: 50Point, Part D claim volume, percentile in specialty: 95 · MIPS quality, percentile: 27Point, Part D claim volume, percentile in specialty: 77 · MIPS quality, percentile: 67Point, Part D claim volume, percentile in specialty: 68 · MIPS quality, percentile: 60Point, Part D claim volume, percentile in specialty: 12 · MIPS quality, percentile: 92Point, Part D claim volume, percentile in specialty: 70 · MIPS quality, percentile: 33Point, Part D claim volume, percentile in specialty: 42 · MIPS quality, percentile: 57Point, Part D claim volume, percentile in specialty: 30 · MIPS quality, percentile: 43Point, Part D claim volume, percentile in specialty: 83 · MIPS quality, percentile: 10Point, Part D claim volume, percentile in specialty: 8 · MIPS quality, percentile: 17Point, Part D claim volume, percentile in specialty: 23 · MIPS quality, percentile: 40Point, Part D claim volume, percentile in specialty: 25 · MIPS quality, percentile: 62Point, Part D claim volume, percentile in specialty: 35 · MIPS quality, percentile: 78Point, Part D claim volume, percentile in specialty: 47 · MIPS quality, percentile: 7Point, Part D claim volume, percentile in specialty: 20 · MIPS quality, percentile: 25Point, Part D claim volume, percentile in specialty: 3 · MIPS quality, percentile: 80Point, Part D claim volume, percentile in specialty: 22 · MIPS quality, percentile: 90Point, Part D claim volume, percentile in specialty: 85 · MIPS quality, percentile: 0Point, Part D claim volume, percentile in specialty: 75 · MIPS quality, percentile: 92Point, Part D claim volume, percentile in specialty: 93 · MIPS quality, percentile: 0Point, Part D claim volume, percentile in specialty: 13 · MIPS quality, percentile: 45Point, Part D claim volume, percentile in specialty: 17 · MIPS quality, percentile: 37Point, Part D claim volume, percentile in specialty: 0 · MIPS quality, percentile: 58Point, Part D claim volume, percentile in specialty: 15 · MIPS quality, percentile: 32Point, Part D claim volume, percentile in specialty: 63 · MIPS quality, percentile: 30Point, Part D claim volume, percentile in specialty: 53 · MIPS quality, percentile: 13Point, Part D claim volume, percentile in specialty: 92 · MIPS quality, percentile: 5Point, Part D claim volume, percentile in specialty: 60 · MIPS quality, percentile: 75Point, Part D claim volume, percentile in specialty: 73 · MIPS quality, percentile: 63Point, Part D claim volume, percentile in specialty: 57 · MIPS quality, percentile: 92Point, Part D claim volume, percentile in specialty: 82 · MIPS quality, percentile: 8Point, Part D claim volume, percentile in specialty: 58 · MIPS quality, percentile: 47Point, Part D claim volume, percentile in specialty: 48 · MIPS quality, percentile: 55Point, Part D claim volume, percentile in specialty: 97 · MIPS quality, percentile: 52Point, Part D claim volume, percentile in specialty: 67 · MIPS quality, percentile: 22Point, Part D claim volume, percentile in specialty: 62 · MIPS quality, percentile: 87Point, Part D claim volume, percentile in specialty: 90 · MIPS quality, percentile: 68Point, Part D claim volume, percentile in specialty: 33 · MIPS quality, percentile: 92Point, Part D claim volume, percentile in specialty: 80 · MIPS quality, percentile: 12Point, Part D claim volume, percentile in specialty: 38 · MIPS quality, percentile: 80Point, Part D claim volume, percentile in specialty: 65 · MIPS quality, percentile: 48Point, Part D claim volume, percentile in specialty: 72 · MIPS quality, percentile: 23Point, Part D claim volume, percentile in specialty: 100 · MIPS quality, percentile: 0Point, Part D claim volume, percentile in specialty: 43 · MIPS quality, percentile: 72Point, Part D claim volume, percentile in specialty: 7 · MIPS quality, percentile: 92Point, Part D claim volume, percentile in specialty: 10 · MIPS quality, percentile: 37Point, Part D claim volume, percentile in specialty: 98 · MIPS quality, percentile: 73Point, Part D claim volume, percentile in specialty: 55 · MIPS quality, percentile: 83Point, Part D claim volume, percentile in specialty: 50 · MIPS quality, percentile: 75Point, Part D claim volume, percentile in specialty: 5 · MIPS quality, percentile: 88Point, Part D claim volume, percentile in specialty: 27 · MIPS quality, percentile: 42Point, Part D claim volume, percentile in specialty: 37 · MIPS quality, percentile: 13Point, Part D claim volume, percentile in specialty: 2 · MIPS quality, percentile: 53Point, Part D claim volume, percentile in specialty: 52 · MIPS quality, percentile: 92Point, Part D claim volume, percentile in specialty: 28 · MIPS quality, percentile: 20Point, Part D claim volume, percentile in specialty: 18 · MIPS quality, percentile: 18Jeffrey Gelfand, M.D., Part D claim volume, percentile in specialty: 40 · MIPS quality, percentile: 65
Part D claim volume vs MIPS quality, by specialty percentile

Each dot is one neurology physician peer from a representative sample of 60; the gold marker is Jeffrey Gelfand, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.

Board certification likely (heuristic, not verified)

Jeffrey Gelfand, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Jeffrey Gelfand, M.D.?

High performer (top quartile)

NPI registry status

Active

Issued 04/11/2008

NPI 1205009115

Primary specialty

Neurology Physician

Mid-sized

20,467 US NPIs in this specialty

Medicare Part D claims

631 53% vs specialty avg

2024 prescription claims

Specialty avg: 1,356

MIPS final score

91.9/100 8.4 pts vs avg

Exceptional band

vs 83.5 national avg

Specialty distribution in California

How Neurology Physician compares to other specialties among California providers

California providers
Behavior Technician17.9%Marriage & Family Therapist5.4%Student in an Organized Heal…5.1%Mental Health Counselor3.7%Pharmacist3.4%Clinical Social Worker3.1%Neurology Physician0.2%
Largest specialties in California (% of in-state providers)

Medicare quality performance, MIPS

Jeffrey Gelfand, M.D.'s 2023 MIPS final score plotted against the Neurology Physician national average

High performer (top quartile)
MIPS Final Score
91.9/100
vs 83.5 national avg · 2023 performance year
0%100%National avg84%91.9%
MIPS final score (Neurology Physician) - 91.9/100 vs national avg 83.5
How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Practice Address

505 PARNASSUS AVE M-798
San Francisco, CA 94143

Provider Details

NPI 1205009115
Specialty Neurology Physician
Credentials M.D.
Gender Male
NPI Issued 04/11/2008

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

91.8508
Final Score
Measured-score avg: 83.5
83.5371
Quality
68.0152
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where Jeffrey Gelfand, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

Ucsf Medical Group Business Services
Burlingame, CA
University OF California Sfgh Medical Group
San Francisco, CA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

License & disciplinary context - California MBC 2023 annual report

Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 - they are NOT specific to Jeffrey Gelfand, M.D.. To verify Jeffrey Gelfand, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

Jeffrey Gelfand, M.D. - brand share 12.0%
Neurology Physician average

12% brand-name claims vs 88% generic, on 631 2024 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2024.

631
Total Claims
$692K
Total Drug Cost
81
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,201.533
Total Day Supply
35,081
Brand vs Generic
12% brand / 88% generic
Brand Drug Cost
$570K
Generic Drug Cost
$122K
Antibiotic Claims
11

Patient Demographics

Average Patient Age
62.8 years
Avg HCC Risk Score
1.83
Gender Split
64% female / 36% male
Age Distribution
<65: 33, 65-74: 34, 75-84: 14, 85+: 0

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.

What Jeffrey Gelfand, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2024

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2024
Drug Claims
Dalfampridine Er
Dalfampridine
68
Baclofen
42
Gabapentin
38
Lamotrigine
34
Fingolimod
Fingolimod Hcl
25
Mycophenolate Mofetil
25
Teriflunomide
23
Levetiracetam
22
Glatiramer Acetate
20
Carbamazepine Er
Carbamazepine
17

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Neurology Physician Overview

How Jeffrey Gelfand, M.D. fits within the Neurology Physician landscape nationally.

20,467
Neurology Physician Providers in US
54
States with Neurology Physician
1,356
Avg Claims per Provider

Jeffrey Gelfand, M.D.'s 631 claims are below the specialty average of 1,356.

Nationwide Neurology Physician peers with similar MIPS or enrollment year

Two federal-record peer sets for Gelfand, both outside California so the neighborhoods are not geographic containment.

Similar MIPS final score

Nearest same-specialty clinicians by CMS MIPS final score (91.9 here).

Same NPPES enumeration year (2008)

Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.

Nearby Neurology Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as Gelfand.

One of 2,160 Neurology Physician providers enrolled in California, 5 are shown here.

Compare Neurology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is Jeffrey Gelfand, M.D.'s specialty?
Jeffrey Gelfand, M.D. specializes in Neurology Physician and practices in San Francisco, California. Credentials: M.D..
How much does Jeffrey Gelfand, M.D. prescribe under Medicare Part D?
In 2024, Jeffrey Gelfand, M.D. wrote 631 Medicare Part D claims totaling $692K in drug costs for 81 beneficiaries.
What is Jeffrey Gelfand, M.D.'s Medicare quality score?
Jeffrey Gelfand, M.D. has a CMS MIPS Final Score of 91.9/100 (Quality: 83.5, Cost: 68). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Jeffrey Gelfand, M.D. located?
Jeffrey Gelfand, M.D. is located at 505 PARNASSUS AVE M-798, San Francisco, CA, 94143. Phone: (415) 476-1489.
What is Jeffrey Gelfand, M.D.'s NPI number?
Jeffrey Gelfand, M.D.'s National Provider Identifier (NPI) is 1205009115, issued on 04/11/2008.
Does Jeffrey Gelfand, M.D. prescribe more brand-name or generic drugs?
Jeffrey Gelfand, M.D.'s prescribing is 12% brand-name and 88% generic drugs by claim count, with $570K in brand drug costs.
How many Neurology Physician providers are there in the US?
There are 20,467 Neurology Physician providers across 54 states in the US. The average Neurology Physician provider writes 1,356 Medicare Part D claims per year.
What drugs does Jeffrey Gelfand, M.D. prescribe most often?
Based on 2024 Medicare Part D data, Jeffrey Gelfand, M.D.'s most frequently prescribed drugs include Dalfampridine Er, Baclofen, Gabapentin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Jeffrey Gelfand, M.D. accept Medicare?
Jeffrey Gelfand, M.D. appears in CMS Medicare data with 631 Part D claims and 81 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Jeffrey Gelfand, M.D.'s credentials?
Jeffrey Gelfand, M.D.'s NPI is 1205009115 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.